At the news
? NEUTRALIMPACT 3/10 COURT-RULING filed Apr 30, 2026 at 20:00 ET
Delaware Chancery Court partially granted Zimmer Biomet's motion to dismiss in an earnout dispute from its acquisition of Embody. Fraud claim allowed to proceed only on alleged misrepresentation about budget approval for sales representatives; breach of contract and implied covenant claims dismissed.
- Acquisition of Embody for $155M upfront plus up to $120M in earnouts; only $72.5M paid.
- Court dismissed breach of contract and implied covenant claims.
- Only one narrow fraud claim survives: representation that Zimmer had budget approval to hire 94 sales representatives.
- Potential damages limited to earnout shortfall (~$47.5M), immaterial relative to $16B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access